Results 41 to 50 of about 221,219 (252)
The ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol, or NHHR, has garnered increased attention because of its connection to metabolic diseases.
Ma Yanming +8 more
doaj +1 more source
BackgroundDyslipidemia is a known independent risk factor for Nonalcoholic fatty liver disease (NAFLD). However, the relationship between NAFLD and the serum non-high-density lipoprotein cholesterol (non-HDL-C) to high-density lipoprotein cholesterol ...
Yanyan Xuan +8 more
doaj +1 more source
ABSTRACT Brown and beige adipocytes dissipate energy as heat, yet effective strategies to enhance their mitochondrial efficiency remain limited. Here, we identify Agnuside (AGN) as a selective stabilizer of the complex I assembly factor NDUFAF6. AGN directly binds cytosolic NDUFAF6, suppresses its ubiquitination, prolongs its half‐life, and facilitates
Qingwen Zhao +7 more
wiley +1 more source
ABSTRACT Diabetes mellitus‐induced erectile dysfunction (DMED) is a highly prevalent complication among diabetic patients; however, its underlying pathogenic mechanisms remain incompletely understood. Metabolic disorder is a hallmark of diabetes, yet its precise contribution to DMED progression is not well defined.
Wanyang Guo +14 more
wiley +1 more source
Are You Targeting Non–High-Density Lipoprotein Cholesterol?
Non–high-density lipoprotein cholesterol (HDL-C) was defined as the second lipid target of therapy in the 2001 National Cholesterol Education Program-Adult Treatment Panel III guidelines ([1][1]), yet is not yet widely used in clinical practice.
openaire +1 more source
Pediatric Non–High-Density Lipoprotein Cholesterol, the Metabolic Syndrome, and Insulin Resistance [PDF]
The article by Li et al in this issue of The Journal presents interesting new data on the cross-sectional association of non-HDL-cholesterol (LDL- and VLDL-cholesterol) with the metabolic syndrome (MetS) in US youth (1) This finding that raises as many issues as it settles, but should guide future analyses into new directions.
Charles J, Glueck, John A, Morrison
openaire +2 more sources
Background Idiopathic membranous nephropathy (IMN) may have various clinical outcomes. Hyperlipidemia is quite common in IMN. However, the utility of the lipid profile in predicting outcomes remains unknown.
Lei Dong, Wang Wei, Min Han, Gang Xu
doaj +1 more source
Non-high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke. [PDF]
Wang Y, Jiang Z, Wu S.
europepmc +3 more sources
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang +32 more
wiley +1 more source
Non-high-density lipoproteins cholesterol and cardiometabolic diseases
At the present stage, non-high-density lipoprotein cholesterol (non-HDL-C) is intensively studied as a predictor of mortality from cardiovascular diseases. An increase in non-HDL-C content is associated with insulin resistance, which is a pathogenetic factor in the development of atherogenic (mixed) dyslipidemia, which is typical for people with ...
A. P. Kashirina, G. I. Simonova
openaire +1 more source

